Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Status: Enrolling
Updated:  12/31/1969
Northwestern University
611
mi
from
Chicago, IL
A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Status: Enrolling
Updated: 12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
889
mi
from
Greer, SC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
889
mi
from
Greer, SC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Alabama Clinical Therapeutics, Llc
688
mi
from
Birmingham, AL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Alabama Clinical Therapeutics, Llc
688
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Fundamental Research
776
mi
from
Gulf Shores, AL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Fundamental Research
776
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
East Valley Family Physicians PLC
845
mi
from
Chandler, AZ
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
East Valley Family Physicians PLC
845
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Desert Clinical Research
841
mi
from
Mesa, AZ
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Desert Clinical Research
841
mi
from
Mesa, AZ
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
853
mi
from
Phoenix, AZ
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
eStudySite
1140
mi
from
Chula Vista, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
eStudySite
1140
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Rocks Medical Research Institute, Inc.
1207
mi
from
Fresno, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Rocks Medical Research Institute, Inc.
1207
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Long Beach Center for Clinical Research
1169
mi
from
Long Beach, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Long Beach Center for Clinical Research
1169
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Saviers Medical Group
1218
mi
from
Port Hueneme, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Saviers Medical Group
1218
mi
from
Port Hueneme, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
University Clinical Investigatons, Inc/Diabetes Research Center
1152
mi
from
Tustin, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
University Clinical Investigatons, Inc/Diabetes Research Center
1152
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Diablo Clinical Research Inc
1317
mi
from
Walnut creek, CA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Diablo Clinical Research Inc
1317
mi
from
Walnut creek, CA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Colorado Springs Health Partners - Briargate
386
mi
from
Colorado Springs, CO
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Colorado Springs Health Partners - Briargate
386
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Meridien Research
1132
mi
from
Bradenton, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Meridien Research
1132
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
East Coast Institute for Research
1063
mi
from
Jacksonville, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
East Coast Institute for Research
1063
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
New Horizon Research Center
1321
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
New Horizon Research Center
1321
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
International Research Assocaites, LLC
1316
mi
from
Miami, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
International Research Assocaites, LLC
1316
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Harmony Clinical Research, Inc.
1314
mi
from
North Miami Beach, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Harmony Clinical Research, Inc.
1314
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Palm Harbor Medical Associates
1099
mi
from
Palm Harbor, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Palm Harbor Medical Associates
1099
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Andres Patron, DO, PA
1306
mi
from
Pembroke Pines, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Andres Patron, DO, PA
1306
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Clinical Research of West Florida, Inc.
1114
mi
from
Tampa, FL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Clinical Research of West Florida, Inc.
1114
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Perimeter Institute for Clinical Research PRIME
800
mi
from
Atlanta, GA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Perimeter Institute for Clinical Research PRIME
800
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Solaris Clinical Research
1053
mi
from
Meridian, ID
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Solaris Clinical Research
1053
mi
from
Meridian, ID
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Chicago Research Center, Inc
605
mi
from
Chicago, IL
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Chicago Research Center, Inc
605
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
American Health Network Of Indiana Llc
630
mi
from
Avon, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
American Health Network Of Indiana Llc
630
mi
from
Avon, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Medisphere Medical Research Center
561
mi
from
Evansville, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Medisphere Medical Research Center
561
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
American Health Network of Indiana LLC
645
mi
from
Franklin, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
American Health Network of Indiana LLC
645
mi
from
Franklin, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
American Health Network of Indiana, LLC
688
mi
from
Muncie, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
American Health Network of Indiana, LLC
688
mi
from
Muncie, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Bunyan Clinical Research
627
mi
from
Valparaiso, IN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Bunyan Clinical Research
627
mi
from
Valparaiso, IN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Crescent City Clinical Research Center
693
mi
from
Metairie, LA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Crescent City Clinical Research Center
693
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Palm Research Center
960
mi
from
Las Vegas, NV
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Palm Research Center
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Pmg Research Of Charlotte
958
mi
from
Charlotte, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Pmg Research Of Charlotte
958
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
1044
mi
from
Durham, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
1044
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Pmg Research Of Salisbury
970
mi
from
Salisbury, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Pmg Research Of Salisbury
970
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
PMG Research of Winston-Salem
976
mi
from
Winston-Salem, NC
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
PMG Research of Winston-Salem
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Sentral Clinical Research Services, LLC
726
mi
from
Cincinnati, OH
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Sentral Clinical Research Services, LLC
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Columbus Clinical Research
820
mi
from
Columbus, OH
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Columbus Clinical Research
820
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Prestige Clinical Research
810
mi
from
Franklin, OH
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Prestige Clinical Research
810
mi
from
Franklin, OH
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Lynn Institute of Norman
176
mi
from
Norman, OK
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Lynn Institute of Norman
176
mi
from
Norman, OK
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Preferred Primary Care Physicians
983
mi
from
Uniontown, PA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Preferred Primary Care Physicians
983
mi
from
Uniontown, PA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
BMG/The Endocrine Clinic
480
mi
from
Memphis, TN
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
BMG/The Endocrine Clinic
480
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Tekton Research
517
mi
from
Austin, TX
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Tekton Research
517
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
3rd Coast Research Associates
688
mi
from
Corpus Christi, TX
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
3rd Coast Research Associates
688
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Galena Research
347
mi
from
Dallas, TX
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Galena Research
347
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
349
mi
from
Dallas, TX
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
349
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
MedStar Clinical Research Associates
570
mi
from
Houston, TX
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
MedStar Clinical Research Associates
570
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
570
mi
from
San Angelo, TX
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
570
mi
from
San Angelo, TX
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Sound Healthcare
1422
mi
from
Port Orchard, WA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Sound Healthcare
1422
mi
from
Port Orchard, WA
Click here to add this to my saved trials
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated:  12/31/1969
Ranier Clinical Research Center
1402
mi
from
Renton, WA
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
An Open-Label Multi-Center Sub-Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes With High Baseline HbA1c
Status: Enrolling
Updated: 12/31/1969
Ranier Clinical Research Center
1402
mi
from
Renton, WA
Click here to add this to my saved trials